Susquehanna International Group’s Black Diamond Therapeutics BDTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $298K | Buy |
120,073
+42,548
| +55% | +$106K | ﹤0.01% | 5046 |
|
|
2025
Q1 | $120K | Buy |
77,525
+42,853
| +124% | +$66.4K | ﹤0.01% | 5789 |
|
|
2024
Q4 | $74.2K | Buy |
+34,672
| New | +$74.2K | ﹤0.01% | 5774 |
|
|
2024
Q3 | – | Sell |
-25,266
| Closed | -$118K | – | 5671 |
|
|
2024
Q2 | $118K | Sell |
25,266
-398,657
| -94% | -$1.86M | ﹤0.01% | 5034 |
|
|
2024
Q1 | $2.15M | Buy |
423,923
+203,613
| +92% | +$1.03M | ﹤0.01% | 1731 |
|
|
2023
Q4 | $619K | Buy |
220,310
+8,991
| +4% | +$25.3K | ﹤0.01% | 3547 |
|
|
2023
Q3 | $606K | Buy |
211,319
+159,833
| +310% | +$459K | ﹤0.01% | 3160 |
|
|
2023
Q2 | $260K | Sell |
51,486
-56,247
| -52% | -$284K | ﹤0.01% | 4380 |
|
|
2023
Q1 | $204K | Buy |
107,733
+41,919
| +64% | +$79.2K | ﹤0.01% | 4852 |
|
|
2022
Q4 | $118K | Sell |
65,814
-23,782
| -27% | -$42.8K | ﹤0.01% | 4862 |
|
|
2022
Q3 | $151K | Sell |
89,596
-40,805
| -31% | -$68.8K | ﹤0.01% | 5012 |
|
|
2022
Q2 | $321K | Buy |
130,401
+109,144
| +513% | +$269K | ﹤0.01% | 3915 |
|
|
2022
Q1 | $59K | Sell |
21,257
-17,180
| -45% | -$47.7K | ﹤0.01% | 5277 |
|
|
2021
Q4 | $205K | Sell |
38,437
-23,029
| -37% | -$123K | ﹤0.01% | 4928 |
|
|
2021
Q3 | $520K | Sell |
61,466
-49,083
| -44% | -$415K | ﹤0.01% | 3650 |
|
|
2021
Q2 | $1.35M | Buy |
110,549
+76,219
| +222% | +$929K | ﹤0.01% | 2581 |
|
|
2021
Q1 | $833K | Buy |
34,330
+24,826
| +261% | +$602K | ﹤0.01% | 3218 |
|
|
2020
Q4 | $305K | Buy |
+9,504
| New | +$305K | ﹤0.01% | 3872 |
|